Você procurou por: nażokomjali (Maltês - Inglês)

żewġ studji qabblu doribax ma’ piperacillin/tazobactam jew ma’ imipenem f’total ta’ 979 pazjent bi pnewmonja nażokomjali;
two studies compared doribax with piperacillin/tazobactam or imipenem in a total of 979 patients with nosocomial pneumonia; two studies compared doribax with meropenem in a total of 962 patients with complicated infections in the abdomen;

doribax kien effettiv daqs l- antibijotiċi l- oħrajn fil- kura ta ’ l- infezzjonijiet: • meta wieħed iħares lejn ir- riżultati taż- żewġ studji fi pnewmonja nażokomjali meħudin flimkien, fiequ 75% tal- pazjenti li kienu qegħdin jirċievu doribax (195 minn 260), meta mqabbla ma ’ 72% ta ’ pazjenti li kienu qegħdin jieħdu piperacillin/ tazobactam jew imipenem (174 minn 241); • meta wieħed iħares lejn ir- riżultati taż- żewġ studji ta ’ infezzjonijiet addominali kkumplikati meħudin flimkien, fiequ 85% tal- pazjenti li kienu qegħdin jirċievu doribax (275 minn 325), meta mqabbla ma ’ 84% tal- pazjenti li kienu qegħdin jirċievu meropenem (260 minn 309); • f’ infezzjonijiet tal- passaġġi awrinarji, fiequ 82% tal- pazjenti li kienu qegħdin jirċievu doribax (230 minn 280), meta mqabbla ma ’ 83% tal- pazjenti li kienu qegħdin jirċievu levofloxacin (221 minn 265).
doribax was as effective as the other antibiotics in treating the infections: • looking at the results of the two studies in nosocomial pneumonia taken together, 75% of the patients receiving doribax were cured (195 out of 260), compared with 72% of the patients taking piperacillin/ tazobactam or imipenem (174 out of 241); • looking at the results of the two studies of complicated abdominal infections taken together, 85% of the patients receiving doribax were cured (275 out of 325), compared with 84% of the patients receiving meropenem (260 out of 309); • in complicated urinary tract infections, 82% of the patients receiving doribax were cured (230 out of 280), compared with 83% of the patients receiving levofloxacin (221 out of 265).